A study shows that an experimental compound has promise for attacking HIV via a new route – cutting off the virus’s pipeline of sugar and nutrients.
Northwestern Medicine scientists explored how HIV uses host factor FEZ-1 to move in cells to the nucleus.
A new Northwestern Medicine study found that testosterone replacement in the United States is more than twice as common among HIV-infected men than the general population.
Scientists at Feinberg are attacking HIV from all sides in an effort to understand, prevent and cure the virus that affects more than 35 million worldwide.
An intravaginal ring, developed by Northwestern scientist Patrick Kiser, is the first device to be tested in women with the potential to protect against HIV, herpes and unwanted pregnancy.
The finding may be useful in shortening drug treatments for those with the disease.
A new intravaginal ring filled with an anti-retroviral drug demonstrated a 100 percent success rate protecting primates from the simian human immunodeficiency virus (SHIV).